Sort   by:  
 Page size 
UnknownCSF Proteomic Alzheimer's Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals.
Not available
S-EPMC8396164 | biostudies-literature
UnknownPathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics.
Not available
S-EPMC7805814 | biostudies-literature
UnknownThe association of diabetes with Alzheimer's disease biomarkers and vascular burden across European aging and memory clinic cohorts.
Not available
S-EPMC12573102 | biostudies-literature
UnknownAmyloid-β, Tau, and Cognition in Cognitively Normal Older Individuals: Examining the Necessity to Adjust for Biomarker Status in Normative Data.
Not available
S-EPMC6027060 | biostudies-literature
UnknownStreptozotocin plus 5-fluorouracil followed by everolimus or the reverse sequence in patients with advanced pancreatic neuroendocrine tumors (SEQTOR-GETNE phase III study): a randomized clinical trial.
Not available
S-EPMC12720089 | biostudies-literature
UnknownCerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.
Not available
S-EPMC5916324 | biostudies-literature
UnknownCerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease.
Not available
S-EPMC8962234 | biostudies-literature
UnknownValidation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.
Not available
S-EPMC7175945 | biostudies-literature
UnknownAPOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer's disease.
Not available
S-EPMC7254647 | biostudies-literature
UnknownCharacteristics of subjective cognitive decline associated with amyloid positivity.
Not available
S-EPMC9786747 | biostudies-literature
Sort   by:  
 Page size